MedPath

International Collaboration of Comprehensive Physiologic Assessment

Completed
Conditions
ST-segment Elevation Myocardial Infarction
Stable Angina
Unstable Angina
Non-ST Elevation Myocardial Infarction
Interventions
Diagnostic Test: Fractional flow reserve, coronary flow reserve, and index of microcirculatory resistance
Registration Number
NCT03690713
Lead Sponsor
Seoul National University Hospital
Brief Summary

The current study evaluated prognostic implication of comprehensive physiologic assessment using fractional flow reserve, coronary flow reserve (CFR) and index of microcirculatory resistance (IMR).

Detailed Description

The patient-level data was gathered from 3 nations (Korea, Japan, Spain). The total 1397 patients (1694 vessels) data was collected from 5 university hospitals in Korea (Seoul National University Hospital, Samsung Medical Centre, Inje University Ilsan Paik Hospital, Keimyung University Dongsan Medical Centre, and Ulsan University Hospital, Korea) and Tsuchiura Kyodo General Hospital, Ibaraki, Japan, and Hospital Clinico San Carlos, Madrid, Spain.

Standardized form of data collection sheet was used and all study adopted standardized definition of patient's baseline characteristics, clinical outcomes, and physiologic data. In case of acute coronary syndrome (unstable angina, non-ST-segment elevation myocardial infarction, and ST-segment elevation myocardial infarction), only non-culprit vessel was included in the data.

Primary outcome is patient- and vessel-oriented composite outcome at 5 years.

Recruitment & Eligibility

Status
COMPLETED
Sex
Not specified
Target Recruitment
1397
Inclusion Criteria
  • patients who underwent clinically indicated invasive coronary angiography and measurements of FFR, CFR, and IMR for at least 1 coronary artery
Exclusion Criteria
  • Patients with hemodynamic instability
  • left ventricular dysfunction
  • culprit vessel of acute coronary syndrome

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Patient and Vessels underwent physiologic evaluationFractional flow reserve, coronary flow reserve, and index of microcirculatory resistanceThe total 1397 patients (1694 vessels) which evaluated using pressure-temperature sensor wire and measured FFR, CFR, and IMR.
Primary Outcome Measures
NameTimeMethod
Cumulative incidence of a composite of any death, any myocardial infarction, or any ischemia-driven revascularization5 year

Patient-oriented composite outcome

Cumulative incidence of a composite of cardiac death, target-vessel related myocardial infarction, or target-vessel revascularization5 year

Vessel-oriented composite outcome

Secondary Outcome Measures
NameTimeMethod
Cumulative incidence of cardiac death5 year

cardiac death

Cumulative incidence of myocardial infarction5 year

MI was defined as elevated cardiac enzyme levels greater than the upper limit of the normal range with either ischemic symptoms or electrocardiography changes indicating ischemia after index procedure. Periprocedural MI was not included as a clinical outcome

Cumulative incidence of ischemia-driven revascularization5 year

Ischemia-driven revascularization was defined as a revascularization procedure with at least one of the following: (1) recurrence of angina; (2) positive non-invasive test; and (3) positive invasive physiologic test

Cumulative incidence of any death5 year

all-cause mortality

Trial Locations

Locations (4)

Samsung Medical Center

🇰🇷

Seoul, Korea, Republic of

Hospital Clinico San Carlos, Madrid, Spain

🇪🇸

Madrid, Spain

Seoul National University Hospital

🇰🇷

Seoul, Korea, Republic of

Tokyo Medical and Dental University

🇯🇵

Tokyo, Japan

© Copyright 2025. All Rights Reserved by MedPath